Brichta L - Search Results

1

Nonsense-mediated messenger RNA decay of survival motor neuron 1 causes spinal muscular atrophy.

Brichta L, Garbes L, Jedrzejowska M, Grellscheid SN, Holker I, Zimmermann K, Wirth B. Brichta L, et al. Hum Genet. 2008 Mar;123(2):141-53. doi: 10.1007/s00439-007-0455-7. Epub 2008 Jan 3. Hum Genet. 2008. PMID: 18172693

2

In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate.

Brichta L, Holker I, Haug K, Klockgether T, Wirth B. Brichta L, et al. Ann Neurol. 2006 Jun;59(6):970-5. doi: 10.1002/ana.20836. Ann Neurol. 2006. PMID: 16607616 Clinical Trial.

3

The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells.

Riessland M, Brichta L, Hahnen E, Wirth B. Riessland M, et al. Among authors: brichta l. Hum Genet. 2006 Aug;120(1):101-10. doi: 10.1007/s00439-006-0186-1. Epub 2006 May 25. Hum Genet. 2006. PMID: 16724231

4

In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy.

Hahnen E, Eyüpoglu IY, Brichta L, Haastert K, Tränkle C, Siebzehnrübl FA, Riessland M, Hölker I, Claus P, Romstöck J, Buslei R, Wirth B, Blümcke I. Hahnen E, et al. Among authors: brichta l. J Neurochem. 2006 Jul;98(1):193-202. doi: 10.1111/j.1471-4159.2006.03868.x. J Neurochem. 2006. PMID: 16805808 Free article.

5

Spinal muscular atrophy: from gene to therapy.

Wirth B, Brichta L, Hahnen E. Wirth B, et al. Among authors: brichta l. Semin Pediatr Neurol. 2006 Jun;13(2):121-31. doi: 10.1016/j.spen.2006.06.008. Semin Pediatr Neurol. 2006. PMID: 17027862 Review.

6

Spinal muscular atrophy and therapeutic prospects.

Wirth B, Brichta L, Hahnen E. Wirth B, et al. Among authors: brichta l. Prog Mol Subcell Biol. 2006;44:109-32. doi: 10.1007/978-3-540-34449-0_6. Prog Mol Subcell Biol. 2006. PMID: 17076267

7

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.

Brichta L, Hofmann Y, Hahnen E, Siebzehnrubl FA, Raschke H, Blumcke I, Eyupoglu IY, Wirth B. Brichta L, et al. Hum Mol Genet. 2003 Oct 1;12(19):2481-9. doi: 10.1093/hmg/ddg256. Epub 2003 Jul 29. Hum Mol Genet. 2003. PMID: 12915451

8

Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number.

Wirth B, Brichta L, Schrank B, Lochmüller H, Blick S, Baasner A, Heller R. Wirth B, et al. Among authors: brichta l. Hum Genet. 2006 May;119(4):422-8. doi: 10.1007/s00439-006-0156-7. Epub 2006 Mar 1. Hum Genet. 2006. PMID: 16508748

9

An approximately 140-kb deletion associated with feline spinal muscular atrophy implies an essential LIX1 function for motor neuron survival.

Fyfe JC, Menotti-Raymond M, David VA, Brichta L, Schäffer AA, Agarwala R, Murphy WJ, Wedemeyer WJ, Gregory BL, Buzzell BG, Drummond MC, Wirth B, O'Brien SJ. Fyfe JC, et al. Among authors: brichta l. Genome Res. 2006 Sep;16(9):1084-90. doi: 10.1101/gr.5268806. Epub 2006 Aug 9. Genome Res. 2006. PMID: 16899656 Free PMC article.

10

Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy.

Fourcade S, Ruiz M, Guilera C, Hahnen E, Brichta L, Naudi A, Portero-Otín M, Dacremont G, Cartier N, Wanders R, Kemp S, Mandel JL, Wirth B, Pamplona R, Aubourg P, Pujol A. Fourcade S, et al. Among authors: brichta l. Hum Mol Genet. 2010 May 15;19(10):2005-14. doi: 10.1093/hmg/ddq082. Epub 2010 Feb 23. Hum Mol Genet. 2010. PMID: 20179078 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters